Proposal to fund two new medicines for type 2 diabetes
Source: Pharmac
What we’re proposing
PHARMAC is seeking feedback on a proposal to fund two new treatments for type 2 diabetes and amend the contractual terms for...
Decision to change the funded brand of labetalol tablets
Source: Pharmac
What we’re doing
PHARMAC has made a decision to make changes to the funded brand of labetalol tablets, which may be used in the...
September 2020 tender notification
Source: Pharmac
30 September 2020
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the...
Decision to list medical devices supplied by Cardinal Health Australia 503 Pty Ltd
Source: Pharmac
What we’re doing
We’re pleased to announce the approval of a listing agreement for the supply of urology products, continence products, surgical suction chest...
Proposal to list haemodialysis equipment and products by Nipro Australia Pty Ltd
Source: Pharmac
What we’re proposing
PHARMAC is seeking feedback on a proposal to list a range of haemodialysis equipment and products in Part III of Section...
PHARMAC seeking views on new type 2 diabetes medicines
Source: Pharmac
9 September 2020
PHARMAC is looking at funding two new oral medicines with substantial health benefits for the 50,000 New Zealanders with type 2...
